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Abstract
Background: The high burden of undiagnosed HIV in sub-Saharan Africa is a major obstacle for HIV prevention and
treatment. Multi-disease, community health campaigns (CHCs) offering HIV testing are a successful approach to rapidly
increase HIV testing rates and identify undiagnosed HIV. However, a greater understanding of population-level uptake is
needed to maximize effectiveness of this approach.
Methods: After community sensitization and a census, a five-day campaign was performed in May 2012 in a rural Ugandan
community. The census enumerated all residents, capturing demographics, household location, and fingerprint biometrics.
The CHC included point-of-care screening for HIV, malaria, TB, hypertension and diabetes. Residents who attended vs. did
not attend the CHC were compared to determine predictors of participation.
Results: Over 12 days, 18 census workers enumerated 6,343 residents. 501 additional residents were identified at the
campaign, for a total community population of 6,844. 4,323 (63%) residents and 556 non-residents attended the campaign.
HIV tests were performed in 4,795/4,879 (98.3%) participants; 1,836 (38%) reported no prior HIV testing. Of 2674 adults
tested, 257 (10%) were HIV-infected; 125/257 (49%) reported newly diagnosed HIV. In unadjusted analyses, adult resident
campaign non-participation was associated with male sex (62% male vs. 67% female participation, p = 0.003), younger
median age (27 years in non-participants vs. 32 in participants; p,0.001), and marital status (48% single vs. 71% married/
widowed/divorced participation; p,0.001). In multivariate analysis, single adults were significantly less likely to attend the
campaign than non-single adults (relative risk [RR]: 0.63 [95% CI: 0.53–0.74]; p,0.001), and adults at home vs. not home
during census activities were significantly more likely to attend the campaign (RR: 1.20 [95% CI: 1.13–1.28]; p,0.001).
Conclusions: CHCs provide a rapid approach to testing a majority of residents for HIV in rural African settings. However,
complementary strategies are still needed to engage young, single adults and achieve universal testing.
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Introduction
The high burden of undiagnosed HIV represents a major
obstacle to implementation of HIV prevention and antiretroviral
treatment (ART) strategies in sub-Saharan Africa. Late HIV
diagnosis translates into missed opportunities for HIV prevention
and delayed antiretroviral treatment resulting in increased HIV-
related morbidity and mortality, and ongoing HIV transmission.
In Uganda, less than 25% of HIV-infected persons are estimated
to be aware of their status, and among 15–49 year olds one-third
of women and over half of men have never tested for HIV [1,2].
Health facility-based approaches to HIV testing in rural Africa
are limited by several factors: cost of patient travel and waiting
time when accessing centralized services, stigma, lack of awareness
of HIV risk, and the minimal or non-specific symptoms
experienced by many patients early in HIV disease [3,4,5].
Provider-initiated voluntary counseling and testing succeeds in
reaching clinic patients who might not otherwise seek testing, but
is dependent on a person seeking medical care [6,7]. As a
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consequence, late presentations to HIV care are common. In a
recent study, the median CD4 count at HIV diagnosis in an urban
Ugandan hospital was ,250 cells/mL [8].
Community health campaigns (CHC) that offer rapid HIV
testing can close the ‘‘gap’’ between those who know and those
who do not know their HIV status. CHCs aim to achieve universal
testing across a community by removing significant barriers to
HIV testing in a high-throughput format. CHCs offer HIV testing
within broader service delivery (such as hypertension screening for
adults and deworming of young children), thereby normalizing
HIV testing as routine health care. CHCs also decentralize testing
locations to minimize travel costs and waiting time, and actively
mobilize community members to attend regardless of perceived
risk. As a consequence, CHCs have succeeded in identifying large
populations of persons reporting no prior testing, and in
diagnosing HIV early [9,10].
We have previously demonstrated high uptake of community-
wide HIV testing with CHCs in rural Uganda [9]. In the present
study, we implemented a census followed by a repeat five-day,
high-throughput HIV testing and referral campaign in order to
better understand barriers to CHC participation for residents of a
rural Ugandan community. This information is critical as CHC
approaches are scaled up to maximize their impact and to develop
complementary testing strategies for nonparticipants.
Methods
In May 2011, a multi-disease community health campaign
(CHC) was conducted in a rural community, Kakyerere parish, in
Mbarara District southwestern Uganda, with the results previously
described [9]. In April and May 2012, an augmented study was
conducted in the same parish, and included community sensiti-
zation, a baseline community census (to accurately measure
participation rates and study reasons for non-participation), and a
multi-disease CHC. We sought to understand predictors of
participation in a CHC, a public-health approach to universal
HIV testing.
Community sensitization
In an effort to maximize campaign uptake, regional and village
political leaders implemented community sensitization activities
one month before the campaign. Routine meetings were held
between the investigators and the village leaders to answer
questions raised by community members and to emphasize that
the campaign services were available to all community residents
regardless of HIV status, age, sex, or prior engagement in clinical
care. Sensitization activities included announcements at local
places of worship and at village gatherings as chosen by village
leaders (including weddings and funerals), and distribution of
colorful posters and flyers describing the campaign services
provided written in both English and Runyankole (the local
language). Campaign services were also described during house-
hold visits in the baseline census.
In addition, as low adult male participation was observed in the
2011 CHC (with men making up 34% of adult participants),
efforts were made to increase male participation in the 2012 CHC
[9]. After soliciting ideas from village leaders to increase male
participation, a targeted incentive of a free T-shirt was introduced
for each adult male participant upon campaign completion. The
T-shirt incentive for men was also promoted during the
community sensitization activities.
Baseline Census
In April 2012 a census was performed to enumerate the baseline
population as the last national census in Uganda occurred in 2002.
With the help of local leaders, census workers enumerated and
collected basic demographics (age, sex, marital status and
occupation) on all household members. Information on household
members not present during a census visit was obtained from the
head of household or other adults. Workers recorded household
locations using handheld global positioning system (GPS) devices
(Etrex Legend H Navigator, Garmin) and fingerprint biometric
measurements (U.are.u 4500, Digital Persona) on all persons home
during the census.
2012 Community Health Campaign
The campaign occurred over five days in May 2012 at four sites
across the community. Well-known public gathering sites (a
market place, a government council headquarters, and two
primary schools) were chosen by the village leaders and
investigators based on their convenience for villagers and to
minimize transport costs and distance traveled reaching the
campaigns. The campaign offered point-of-care (POC) HIV,
hypertension and diabetes screening, tuberculosis (TB) symptom
screening for all, and malaria testing for participants with self-
reported fever, as previously described [9]. All participants
screening HIV antibody positive underwent confirmatory testing
with a POC rapid testing algorithm, followed by POC CD4+ T
cell count testing (PIMA, Inverness Medical) [9]. They then
received on-site post-test counseling, and were given an appoint-
ment to the local health center for HIV treatment. Finger-prick
diagnostics eliminated the need for phlebotomy at the campaign.
Statistical Methods
Residence in Kakyerere parish was defined by enumeration in
the census. Self-report during the campaign questionnaire was also
accepted to define parish residence, but only if the participant
could name a household member identified in the census.
Fingerprint biometric measures were used to verify resident
identity upon campaign registration; if fingerprinting failed, name-
based matching was used. The prevalence of each disease was
Figure 1. Population distribution of Kakyerere parish as
determined from a twelve-day study census (open blue and
red bars), and Community Health Campaign participation over
five days among residents (solid blue and red bars), by age and
sex.
doi:10.1371/journal.pone.0084317.g001
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estimated with the sample proportion, where the number of
participants tested for each disease served as the denominator.
Unadjusted analyses of variables affecting CHC attendance
among adults residents were based on Pearson’s Chi-squared test
for proportions, Student’s t-test for means and the Wilcoxon rank
sum test for medians. For a set of a priori specified characteristics
(sex, single marital status and in-person contact at the census),
adjusted analyses were based on targeted minimum loss-based
estimation (TMLE) [11]. Specifically, TMLE was used to estimate
the relative risk of each variable of interest, after controlling for the
other factors and age continuously. Unlike standard logistic
regression, TMLE avoids parametric modeling assumptions and
yields marginal (unconditional) estimates.
Ethics statement
Verbal consent was obtained for all participants in order to
maintain anonymity during HIV testing at the community health
campaign, as written consent would have been the only name-
linked identifier between a participant and his/her HIV test result.
Campaign uptake was linked to the census data by a digital
fingerprint biometric alone. Children from 13–17 years could
provide verbal consent if a parent/guardian was not present,
consistent with Uganda MOH policy [12]. Children ,13 years
could not participate without an assenting parent/guardian
present. Verbal consent was documented by study staff for each
study participant during the census and at entry into the
campaign, and linked to an anonymous study identification
number. The Makerere University School of Medicine Research
and Ethics Committee, the Ugandan National Council on Science
and Technology, and the UCSF Committee on Human Research
approved the consent procedures and the study.
Results
Census
Over 12 days in April 2012, 18 census workers enumerated
6,343 parish residents (29 residents/day per worker). Based on
population projections from the 2002 Ugandan Census, there
were an estimated 6,400 Kakyerere parish residents in 2012 [13].
4,247 (67%) residents were at home during the census, and 2,096
residents (33%) were enumerated but not at home. Of 4,247
residents at home during the census, 4,071 (96%) provided
fingerprint biometric measures, and 176 (4%) declined. 3,149
(50%) of residents enumerated in the census were adults
(.18 years), of whom 1,714 (54%) were female. Adults were
home during census visits more often than children (2345/3149
[74%] vs. 1902/3194 [60%], respectively). Among adults, women
were more likely to be home during census visits than men (1396/
1714 [81%] vs. 949/1435 [66%]; p,0.001), and the median age
was greater among residents at home (32 [IQR: 24–45] years) than
residents not at home (25 [IQR: 20–38] years; p,0.001). Married,
widowed and divorced/separated adults were also more likely to
be home than single adults (1850/2262 [82%] vs. 493/880 [56%],
respectively; p,0.001). During the health campaign, 501 persons
not enumerated in the census reported residence in the community
and could name a specific household member from the census, for
a total parish population of 6,844 people.
Community Health Campaign
In five days, 4,879 people participated in the health campaign
for an average of 976 participants/day. 4,282 (63%) of 6,844
community residents participated (see Figure 1), and 597/4,879
(12%) participants were non-residents from neighboring commu-
nities. Overall, 55% (2,687/4,879) of participants were adults, and
1,249 (46%) adult participants were men (see Figure 2). HIV tests
were performed in 4,795/4,879 (98.3%) participants, of whom
1,836 (38%) reported no prior HIV testing. Of 257 HIV-infected
adults, 125 (49%) reported newly diagnosed HIV. Median CD4
count among newly diagnosed adults was 436 cells/mL and 90
(72%) had a CD4 cell count .350 cells/mL. Among HIV-infected
adults, 199/257 (77%) had at least one of four TB symptoms
recommended by the WHO for intensified TB case finding [14].
Among HIV-uninfected adults, 318/2,417 (13%) reported cough
for .2 weeks. 1,234/4,879 (25%) of CHC participants reported
fever, and 51 (4%) tested positive for malaria by RDT. The
prevalence of hypertension and diabetes among adult participants
was 18% and 2%, respectively. Screening results are shown in
Table 1. Among adult residents participating in the campaign,
1,071/2,204 (51%) reported attending our CHC held in the same
community in May 2011. The final campaign day was at the local
Figure 2. Change in male and female participation from a 2011 to a 2012 community health campaign (CHC) in Kakyerere parish, a
rural Ugandan community. Shown are the age and sex distribution of CHC participants, including non-residents of the community, by year. The
dashed arrow indicates the low proportion of adult male participants in the 2011 CHC.
doi:10.1371/journal.pone.0084317.g002
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trading center on a weekend market day. A significantly greater
proportion of adults attending the trading center site, compared to
the other three campaign sites, were male (55% vs. 44%;
p,0.001), single (26% at trading center vs. 20% at other sites;
p = 0.001), and younger (median age: 30 vs. 34 years; p,0.001).
Predictors of campaign participation
Of 6,844 community residents, 4,282 (63%) residents partici-
pated and 2,562 (37%) residents did not participate in the
campaign. Adult residents were more likely to participate than
children (2,204/3,446 [64%] vs. 2,078/3,398 [61%], respectively;
unadjusted p = 0.017). In unadjusted analyses, adult participants
compared to non-participants were more likely to be female
(1222/1843 [66%] women vs. 982/1,603 [61%] men participated;
p = 0.002), older (median age: 32 [IQR: 24–45] years in
participants vs. 27 [22–38] in non-participants; p,0.001), non-
single (70% of married/widowed/divorced vs. 48% single adults
participated; p,0.001), farmers (75% of farmers vs. 51% of non-
farmers participated; p,0.001) and to have been home during the
census (70% adults at home vs. 34% not at home participated;
p,0.001). Figure 3 shows the proportion of each sex and age
group that attended the campaign. The average distance from
household to nearest campaign site was not significantly different
in campaign participants (1.14 km) vs. non-participants (1.08 km;
p = 0.87). Campaign participation by the head of household was
significantly associated with campaign participation by other
household members (68% [2,041/3,516] participation if house-
hold head participated vs. 41% [695/1,680] participation if
household head did not participate; p,0.001).
After multivariate adjustment with TMLE, the estimated
probability of attending the campaign was significantly lower
among single compared to non-single adults (RR: 0.63; p,0.001
after adjusting for sex, being home during the census and age), and
among adults who were not at home vs. at home during the census
(adjusting for sex, single marital status, and age, RR: 0.83;
p,0.001), whereas sex was no longer significantly associated with
participation (Table 2).
Discussion
Our findings demonstrate the continued yield of multi-disease,
community health campaign (CHC)-based HIV testing in
identifying persons with no prior testing and with undiagnosed
HIV infection in a community with year-round access to facility-
based testing. Using rigorous methods to define community
Table 1. Screening results by disease during a five-day Community Health Campaign in Kakyerere parish, Uganda.
Community Health Campaign Participants N = 4,879
Number of participants
screening positive %
HIV (N = 4,795 tested)
Children (,18 years) (N = 2,121) 12 1%
Adult (.18 years) (N = 2,674) 257 10%
Median CD4 count, adults (N = 210) 426 cells/mL IQR: 306–613
New diagnoses in HIV-infected adults (N = 257) 125 49%
Median CD4 in newly diagnosed adults (N = 101) 436 cells/mL IQR: 306–617
TB symptoms, adults (N = 2,674 screened)
HIV-uninfected (N = 2,417)
Cough .2 weeks 318 13%
HIV-infected (N = 257)
Current cough 89 35%
Fever 81 32%
Weight loss 83 32%
Night sweats 125 49%
Any of above 4 symptoms 199 77%
Malaria (N = 4,879 screened for fever)
Self-reported fever 1234 25%
Confirmed malaria, if febrile 51 4%
Age ,10 years (N = 341) 27 8%
Age .10 years (N = 893) 24 3%
Hypertension, adults (N = 2,687 screened)
Systolic.140 or diastolic.90 mmHg, or prior self-reported diagnosis 483 18%
Diabetes, adults (N = 2,672 screened)
Adults with positive screening test 63 2%
New adult diagnoses 18 29%
Smoking (self-report)
Men (N = 1246 screened) 393 32%
Women (N = 1437 screened) 152 11%
doi:10.1371/journal.pone.0084317.t001
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residence, including a baseline census with fingerprint biometric
measurements for identification, we found that young, single
adults were significantly less likely than older, non-single adults to
access HIV-testing via CHCs, suggesting that novel testing
approaches are needed to reach this high-risk group.
Multi-disease CHCs have been successfully implemented in
Uganda and Kenya and represent an effective and rapid strategy
for scale-up of HIV testing services in rural, resource-limited
settings [9,10]. Although several modalities for non-facility based
testing have been successfully implemented in rural Africa,
including home-based testing (HBT) and mobile testing vans,
CHCs offer the advantages of acting as a platform for multi-
disease testing and rapid scale-up to population coverage in a
period of days. With point-of-care CD4 count testing and co-
location of HIV clinic staff at the CHC, the early cascade of HIV
care (testing, counseling and disease staging) can be performed in a
single encounter taking less than three hours. Multi-disease service
provision may also encourage repeat HIV testing or testing on a
regular basis, which is likely to be a necessary part of any ‘‘test and
treat’’ approach, and indeed we found that half of the campaign
participants reported HIV testing at a CHC held one year prior.
However, our findings also suggest that complementary
approaches will be needed to achieve universal HIV testing across
a population. By understanding how uptake varies with testing
strategy, non-facility based testing strategies may be optimized to
achieve universal testing coverage. Factors found to decrease
uptake of home-based HIV testing (HBT) have varied consider-
ably depending on the population studied, and include older age
(.25 years) [4], as well as young adulthood [15], having a
concurrent partnership at the time of HBT [4], lack of
participation by the male head of household [16], single marital
status, higher educational attainment [17], and high (.30%) prior
rates of HIV testing in a community [18]. In our study population
several factors were associated with lower testing uptake, notably
younger age and single marital status. How these factors influence
testing at CHCs remains unknown and multiple causal pathways
are likely at play. For example, increased testing uptake with older
age may be due to interest in the non-communicable disease
screening offered at CHCs, whereas increased uptake among
persons whose head of household participated in testing suggests
that social networks influence CHC participation.
Low HIV testing uptake among young adults is a particularly
important challenge due to the high HIV risk they face as they
enter adulthood, and the enormous opportunity for HIV
prevention among African youth. Despite the high risk of HIV
faced by young adults, their testing rates are among the lowest of
any demographic, particularly among young men, [19,20,21] and
neither CHCs nor home-based testing approaches are immune to
this [15]. A better understanding of the reasons for low HIV
testing uptake among young, single adults and their perception of
HIV risk is needed, and could inform novel approaches to
reaching young adults and adolescents. Lower engagement by
young adults in HIV prevention activities is not limited to HIV
testing. Trials of HIV prevention interventions, such as pre-
exposure prophylaxis with oral tenofovir-containing regimens have
also found lower adherence as measured by drug levels among
young women (age ,25 years) and unmarried women in sub-
Saharan Africa, further highlighting the challenges in HIV
prevention interventions among young adults [22]. In spite of this
challenge, community (non-facility) based HIV testing approaches
such as CHCs have achieved higher testing uptake among young
adults than health facility based testing and represent an
opportunity to engage young adults in their communities for
HIV prevention messaging and interventions. The relatively
higher rate of young adult testing in the CHC seen at the
marketplace also suggests that selecting testing sites with optimal
convenience for young, working adults may increase testing
uptake, and merits further exploration.
Despite lower rates of participation by young adults, adult male
CHC participation was increased in the 2012 campaign to nearly
half of adult participants (see Figure 2). Through a process of
soliciting village leader input for a specific barrier to CHC uptake,
incentives may have played a significant role in increasing male
Figure 3. Proportion of residents attending the 2012 commu-
nity health campaign (CHC) according to sex and age group
among residents $15 years old. The dashed vertical lines indicate
95% confidence intervals.
doi:10.1371/journal.pone.0084317.g003
Table 2. Results from the unadjusted and adjusted analyses of the a priori-specified variables of interest on the relative risk (RR) of
CHC attendance.
Variable Unadjusted RR 95% CI p-value Adjusted RR 95% CI p-value
Male 0.92 0.89–0.98 0.002 0.99 0.94–1.04 0.76
Single 0.68 0.63–0.73 ,0.001 0.63 0.53–0.74 ,0.001
Contacted during census 1.33 1.25–1.41 ,0.001 1.20 1.13–1.28 ,0.001
The reference groups were female, married/widowed/divorced/separated and not-contacted, respectively. The adjusted analyses (TMLE) controlled for the other factors
and age continuously.
doi:10.1371/journal.pone.0084317.t002
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CHC participation, as has been described in a mobile testing
approach in South Africa [23]. Several factors may have
contributed to increased male participation in 2012 as well, such
as increased familiarity with the campaign from the 2011 CHC,
and inclusion of a marketplace as a campaign site. Lower HIV
testing rates among men compared to women has been well
described in a variety of settings, [9,10,21,24] and likely
contributes to lower rates of ART uptake in men [25,26]. CHCs,
incorporating input from local leadership, multi-disease services
and simple incentives, offer a means of rapidly increasing adult
male HIV testing uptake and reaching populations that might
otherwise ‘‘fall through the cracks’’ of facility-based testing.
Our study has several limitations. The campaign was designed
to accommodate 1,000 persons per day, and was limited to
five days. The additional testing yield of having more campaign
days, particularly among young, single adults, remains unknown.
In addition, on the only campaign day occurring on a weekend, we
observed a significantly younger median age and a greater
proportion of single and male adults than the other four campaign
days. This suggests that the lower participation rates of young,
single adults may have been due in part to conflicts with their work
schedules rather than lack of interest. The incentive used, a free T-
shirt for adult males, was chosen by this community’s leadership,
and might not be effective or feasible in a different setting. Finally,
our finding that being home during the census was significantly
associated with campaign participation may reflect migration
patterns, with persons not available during the census at higher
likelihood of being away from home during the campaign days,
rather than a mobilizing effect of the census. Despite these
limitations, our data provide a rigorous evaluation of uptake of
HIV testing using a CHC approach in a rural Ugandan
community.
Conclusions
In light of the increasing number of effective biomedical options
for HIV prevention among both HIV-infected and uninfected
persons, and increased access to antiretroviral therapy in sub-
Saharan Africa, the opportunities for reducing HIV-associated
morbidity and mortality and dramatically reducing HIV trans-
mission are greater than ever, but depend on knowing one’s HIV
status. Achieving universal HIV testing across large populations
will likely require several complementary testing approaches.
Multi-disease community health campaigns provide a rapid means
of jump-starting this process, and will serve as the engine driving
universal HIV testing in the SEARCH ‘‘test and treat’’ cluster
randomized-control trial we are conducting in East Africa,
comparing universal HIV testing with antiretroviral therapy
(ART) start at any CD4+ T cell count vs. CD4-guided ART start.
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